iqvia weight loss prescriptions semaglutide tirzepatide q3 2024 Eli Lilly Stock Will 'Dominate' GLP-1 Market in With Zepbound Top 15 Diabetes Drugs in

Q2 2025 Snapshot Eli Lilly and Company dominates the US 57 % GLP-1 share, led by Mounjaro (tirzepatide) HCP & Zepbound (tirzepatide) HCP Novo Nordisk rules Europe 63 % value share, powered by Wegovy(semaglutide) injection 2.4 mg HCP & Ozempic APAC & Emerging Markets are the next frontier (+1113 % YoY) Together, they crossed $24 Billion in H1 2025 GLP-1 revenue proving the real blockbuster of this decade isnt oncology or immunology Its metabolic health

For athletes and fitness enthusiasts, glutathione IV therapy can be transformative

Current research focuses on enhancing transdermal absorption through various technologies including microneedle patches, chemical penetration enhancers, and modified drug formulations

MSDC-0602K is a second-generation thiazolidinedione designed to preferentially suppress the mitochondrial pyruvate carrier while minimizing direct binding to PPAR

S., Kraft, G